Figure 1.
Figure 1. Characterization of CD14+/VEGFR-2+ and CD14+/VEGFR-2- cells. (A) Flow cytometry sorting of CD14+/VEGFR-2+ and CD14+/VEGFR-2- from PBMCs depleted of T lymphocytes. (B) CD14+/VEGFR-2- cells did not express e-NOS. (C) CD14+/VEGFR-2+ cells expressed several endothelial-specific markers such as e-NOS (black), VWF (red), and thrombomodulin (red), and some cells expressed CD133 (red) but not CD144. Cells were counterstained with hematoxylin. Magnification, 40 ×. (D) Western blotting of the lysates from CD14+/VEGFR-2+ cells with antibodies to VEGFR-2 gave the expected bands of approximately 200 kDa (lanes 1-2), whereas CD14+/VEGFR-2- cells (lane 3) and the control secondary antibody did not (lane 4). (E) mRNA expression for e-NOS was detected strongly in CD14+/VEGFR-2+ cells and weakly in CD14+/VEGFR-2- cells. N indicates nucleus.

Characterization of CD14+/VEGFR-2+ and CD14+/VEGFR-2- cells. (A) Flow cytometry sorting of CD14+/VEGFR-2+ and CD14+/VEGFR-2- from PBMCs depleted of T lymphocytes. (B) CD14+/VEGFR-2- cells did not express e-NOS. (C) CD14+/VEGFR-2+ cells expressed several endothelial-specific markers such as e-NOS (black), VWF (red), and thrombomodulin (red), and some cells expressed CD133 (red) but not CD144. Cells were counterstained with hematoxylin. Magnification, 40 ×. (D) Western blotting of the lysates from CD14+/VEGFR-2+ cells with antibodies to VEGFR-2 gave the expected bands of approximately 200 kDa (lanes 1-2), whereas CD14+/VEGFR-2- cells (lane 3) and the control secondary antibody did not (lane 4). (E) mRNA expression for e-NOS was detected strongly in CD14+/VEGFR-2+ cells and weakly in CD14+/VEGFR-2- cells. N indicates nucleus.

Close Modal

or Create an Account

Close Modal
Close Modal